168 related articles for article (PubMed ID: 32930470)
1. Generation of hypoimmunogenic human pluripotent stem cells via expression of membrane-bound and secreted β2m-HLA-G fusion proteins.
Shi L; Li W; Liu Y; Chen Z; Hui Y; Hao P; Xu X; Zhang S; Feng H; Zhang B; Zhou S; Li N; Xiao L; Liu L; Ma L; Zhang X
Stem Cells; 2020 Nov; 38(11):1423-1437. PubMed ID: 32930470
[TBL] [Abstract][Full Text] [Related]
2. Hypoimmunogenic human pluripotent stem cells are valid cell sources for cell therapeutics with normal self-renewal and multilineage differentiation capacity.
Chen Y; Zhou Y; Zhou Z; Fang Y; Ma L; Zhang X; Xiong J; Liu L
Stem Cell Res Ther; 2023 Jan; 14(1):11. PubMed ID: 36691086
[TBL] [Abstract][Full Text] [Related]
3. Generation of universal and hypoimmunogenic human pluripotent stem cells.
Ye Q; Sung TC; Yang JM; Ling QD; He Y; Higuchi A
Cell Prolif; 2020 Dec; 53(12):e12946. PubMed ID: 33174655
[TBL] [Abstract][Full Text] [Related]
4. Targeted Disruption of the β2-Microglobulin Gene Minimizes the Immunogenicity of Human Embryonic Stem Cells.
Wang D; Quan Y; Yan Q; Morales JE; Wetsel RA
Stem Cells Transl Med; 2015 Oct; 4(10):1234-45. PubMed ID: 26285657
[TBL] [Abstract][Full Text] [Related]
5. Generating hypoimmunogenic human embryonic stem cells by the disruption of beta 2-microglobulin.
Lu P; Chen J; He L; Ren J; Chen H; Rao L; Zhuang Q; Li H; Li L; Bao L; He J; Zhang W; Zhu F; Cui C; Xiao L
Stem Cell Rev Rep; 2013 Dec; 9(6):806-13. PubMed ID: 23934228
[TBL] [Abstract][Full Text] [Related]
6. Generation of individualized immunocompatible endothelial cells from HLA-I-matched human pluripotent stem cells.
Song C; Wang L; Li Q; Liao B; Qiao W; Li Q; Dong N; Li L
Stem Cell Res Ther; 2022 Feb; 13(1):48. PubMed ID: 35109922
[TBL] [Abstract][Full Text] [Related]
7. Hypoimmunogenic Human Pluripotent Stem Cells as a Powerful Tool for Liver Regenerative Medicine.
Trionfini P; Romano E; Varinelli M; Longaretti L; Rizzo P; Giampietro R; Caroli A; Aiello S; Todeschini M; Casiraghi F; Remuzzi G; Benigni A; Tomasoni S
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511568
[TBL] [Abstract][Full Text] [Related]
8. A strategy to protect off-the-shelf cell therapy products using virus-specific T-cells engineered to eliminate alloreactive T-cells.
Quach DH; Becerra-Dominguez L; Rouce RH; Rooney CM
J Transl Med; 2019 Jul; 17(1):240. PubMed ID: 31340822
[TBL] [Abstract][Full Text] [Related]
9. Universal and hypoimmunogenic pluripotent stem cells for clinical usage.
Sung TC; Maitiruze K; Pan J; Gong J; Bai Y; Pan X; Higuchi A
Prog Mol Biol Transl Sci; 2023; 199():271-296. PubMed ID: 37678974
[TBL] [Abstract][Full Text] [Related]
10. T-Cell Mediated Immune Rejection of Beta-2-Microglobulin Knockout Induced Pluripotent Stem Cell-Derived Kidney Organoids.
Gaykema LH; van Nieuwland RY; Lievers E; Moerkerk WBJ; de Klerk JA; Dumas SJ; Kers J; Zaldumbide A; van den Berg CW; Rabelink TJ
Stem Cells Transl Med; 2024 Jan; 13(1):69-82. PubMed ID: 37843402
[TBL] [Abstract][Full Text] [Related]
11. Maintenance of Hypoimmunogenic Features
An JH; Koh H; Ahn Y; Kim J; Han AR; Lee JY; Kim SU; Lee JH
Front Bioeng Biotechnol; 2022; 10():936584. PubMed ID: 36032723
[TBL] [Abstract][Full Text] [Related]
12. HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells.
Gornalusse GG; Hirata RK; Funk SE; Riolobos L; Lopes VS; Manske G; Prunkard D; Colunga AG; Hanafi LA; Clegg DO; Turtle C; Russell DW
Nat Biotechnol; 2017 Aug; 35(8):765-772. PubMed ID: 28504668
[TBL] [Abstract][Full Text] [Related]
13. CRISPR/Cas9 and AAV mediated insertion of β2 microglobulin-HLA-G fusion gene protects mesenchymal stromal cells from allogeneic rejection and potentiates the use for off-the-shelf cell therapy.
Meshitsuka S; Ninomiya R; Nagamura-Inoue T; Okada T; Futami M; Tojo A
Regen Ther; 2022 Dec; 21():442-452. PubMed ID: 36313397
[TBL] [Abstract][Full Text] [Related]
14. HLA Class I Depleted hESC as a Source of Hypoimmunogenic Cells for Tissue Engineering Applications.
Karabekian Z; Ding H; Stybayeva G; Ivanova I; Muselimyan N; Haque A; Toma I; Posnack NG; Revzin A; Leitenberg D; Laflamme MA; Sarvazyan N
Tissue Eng Part A; 2015 Oct; 21(19-20):2559-71. PubMed ID: 26218149
[TBL] [Abstract][Full Text] [Related]
15. Generation of B2M bi-allelic knockout human induced pluripotent stem cells (MUSIi001-A-1) using a CRISPR/Cas9 system.
Thongsin N; Wattanapanitch M
Stem Cell Res; 2021 Oct; 56():102551. PubMed ID: 34628247
[TBL] [Abstract][Full Text] [Related]
16. Fit-For-All iPSC-Derived Cell Therapies and Their Evaluation in Humanized Mice With NK Cell Immunity.
Flahou C; Morishima T; Takizawa H; Sugimoto N
Front Immunol; 2021; 12():662360. PubMed ID: 33897711
[TBL] [Abstract][Full Text] [Related]
17. Selective deletion of human leukocyte antigens protects stem cell-derived islets from immune rejection.
Parent AV; Faleo G; Chavez J; Saxton M; Berrios DI; Kerper NR; Tang Q; Hebrok M
Cell Rep; 2021 Aug; 36(7):109538. PubMed ID: 34407395
[TBL] [Abstract][Full Text] [Related]
18. Generation of Mesenchymal Stromal Cells with Low Immunogenicity from Human PBMC-Derived β2 Microglobulin Knockout Induced Pluripotent Stem Cells.
Zha S; Tay JC; Zhu S; Li Z; Du Z; Wang S
Cell Transplant; 2020; 29():963689720965529. PubMed ID: 33172291
[TBL] [Abstract][Full Text] [Related]
19. The Impact of HLA Class I-Specific Killer Cell Immunoglobulin-Like Receptors on Antibody-Dependent Natural Killer Cell-Mediated Cytotoxicity and Organ Allograft Rejection.
Rajalingam R
Front Immunol; 2016; 7():585. PubMed ID: 28066408
[TBL] [Abstract][Full Text] [Related]
20. High-Specificity CRISPR-Mediated Genome Engineering in Anti-BCMA Allogeneic CAR T Cells Suppresses Allograft Rejection in Preclinical Models.
Degagné É; Donohoue PD; Roy S; Scherer J; Fowler TW; Davis RT; Reyes GA; Kwong G; Stanaway M; Larroca Vicena V; Mutha D; Guo R; Edwards L; Schilling B; Shaw M; Smith SC; Kohrs B; Kufeldt HJ; Churchward G; Ruan F; Nyer DB; McSweeney K; Irby MJ; Fuller CK; Banh L; Toh MS; Thompson M; Owen ALG; An Z; Gradia S; Skoble J; Bryan M; Garner E; Kanner SB
Cancer Immunol Res; 2024 Apr; 12(4):462-477. PubMed ID: 38345397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
